High-yield points
- Incidence: childhood AIS is about 1.6 per 100,000 per year, highest in infancy. Diagnosis is often delayed .
- Recurrence: 12% at 1 year, and 5-fold higher with arteriopathy (moyamoya 32%) .
- IV alteplase within 4.5 hours: symptomatic hemorrhage risk about 2% in children .
- Thrombectomy for large- or medium-vessel occlusion was associated with better function than medical care in non-randomized cohorts (Save ChildS Pro), even with large cores .
- FCA: less clear benefit from thrombectomy; it often progresses over the first 1–2 weeks .
- Malignant MCA infarction: decompressive hemicraniectomy changes 67% mortality to about 95% survival in pooled pediatric cases .
- Sickle cell: TCD ≥200 cm/s means chronic transfusion to HbS <30%, giving 92% fewer strokes .
Landmark papers
- STOP (Adams et al., N Engl J Med 1998): 130 children with sickle cell disease and TCD velocity of 200 cm/s or more. Chronic transfusion to HbS below 30% gave 92% fewer first strokes (1 vs 11 events), and the trial stopped early .
- VIPS (Fullerton et al., Stroke 2016): 355 children. Cumulative recurrence was 6.8% at 1 month and 12% at 1 year, and arteriopathy raised risk 5-fold (HR 5.0) .
- Save ChildS Pro (Sporns et al., Lancet Child Adolesc Health 2024): a prospective registry of 208 children with large- or medium-vessel occlusion. Median mRS worsening was 1 with thrombectomy vs 2 with best medical treatment (p = 0.020) .
Childhood arterial ischemic stroke (AIS) is rare, often missed, and caused by different diseases than adult stroke.
- The usual causes: arteriopathy, cardiac embolism and sickle cell disease, rather than atherosclerosis.
- Acute reperfusion has caught up with adult practice:
- thrombectomy for large- or medium-vessel occlusion now has prospective pediatric data;
- IV alteplase appears safe in older children within 4.5 hours.
- The neurosurgeon's roles:
- decompressive hemicraniectomy for malignant MCA infarction;
- posterior fossa decompression for cerebellar infarction;
- revascularization for moyamoya (see Moyamoya) .
Epidemiology and recognition
- Incidence of pediatric stroke (all types, neonatal through childhood) :
- 3–25 per 100,000 children per year in developed countries.
- Newborns carry the highest risk: 1 in 4,000 live births.
- Delays in diagnosis are common.
- Childhood AIS, prospective population study (southern England) :
- Incidence: 1.60 per 100,000 per year, highest under age 1 (4.14).
- Presentation: focal features, mostly hemiparesis, in 85%. Seizures were more common in infants and headache in children over 5.
- Risk factors: at least one in 83%.
- Recurrence (VIPS, 355 children) :
- Cumulative recurrence: 6.8% at 1 month and 12% at 1 year, despite antithrombotics in 87%.
- Arteriopathy raised risk 5-fold (HR 5.0). One-year recurrence by type:
- moyamoya 32%;
- transient cerebral arteriopathy 25%;
- dissection 19%.
- Focal cerebral arteriopathy (FCA) :
- Pattern: unilateral stenosis of the distal ICA, A1, M1 and proximal branches in previously healthy children.
- Progression: 73% progressed on follow-up imaging, peaking at a median of 8 days.
- Severity score: higher maximum scores (FCASS) correlated with worse 1-year outcome.
Acute reperfusion
- IV alteplase (tPA) :
- The trial: TIPS (Thrombolysis in Pediatric Stroke) closed for lack of accrual.
- The data since: 26 children at former TIPS sites, aged 1.1–17 (median 14), median PedNIHSS 14, treated at 2–4.5 hours. None had symptomatic intracranial hemorrhage.
- Bayesian estimate of symptomatic hemorrhage risk: about 2.1% (95% interval 0–6.7%).
- Bottom line: risk appears low within 4.5 hours in children.
- Mechanical thrombectomy:
- IPD meta-analysis (110 patients) :
- Results: good long-term outcome (mRS 0–2) in 90.6% and recanalization (mTICI 2b/3) in 87.8%; one symptomatic hemorrhage.
- The authors' recommendation: consider thrombectomy for ICA terminus, M1 or basilar occlusion at ages 1–18 (class IIb, level C).
- Save ChildS Pro (prospective registry, 45 centers, 208 children aged 28 days to 18 years with large- or medium-vessel occlusion) :
- Arms: thrombectomy (n = 117) vs. best medical treatment (n = 91).
- Functional change: median mRS worsening from baseline was 1 vs. 2 (p = 0.020), and the benefit held after propensity matching.
- Safety: 1 symptomatic hemorrhage; mortality 5% in both arms.
- Suspected FCA: no significant difference.
- Large baseline infarct (ASPECTS 0–5, 40 children aged 1–18) :
- Outcome: thrombectomy gave better 90-day pediatric mRS (OR 3.68) with no excess symptomatic hemorrhage.
- Implication: don't exclude a child on a low ASPECTS alone.
- Practical workflow (see caveats):
- Imaging: rapid MRI (DWI plus MRA) or CT/CTA to confirm an occlusion and exclude mimics, which are common in children.
- Call a pediatric stroke team with neurointerventional input.
- Treatment: alteplase within 4.5 hours if eligible, and thrombectomy for a large-vessel occlusion.
Surgery for malignant edema
- Decompressive hemicraniectomy:
- Pooled pediatric cases (97 children, 26 reports) :
- Without decompression: 67% mortality.
- With it: 95.4% survival, median mRS 2.1 at about 32 months.
- Timing: survivors did well even when surgery was delayed.
- International Pediatric Stroke Study (4,294 children) :
- Numbers: 38 (1%) had craniectomy: 29 for anterior circulation stroke, 5 posterior circulation and 4 CSVT.
- Outcome: mortality 8%, but survivors had significant deficits.
- Posterior circulation: suboccipital decompression, with or without external ventricular drainage, for swelling cerebellar infarcts causing brainstem compression or hydrocephalus (see caveats).
Secondary prevention and special groups
- Antithrombotics: recurrence clusters early and in arteriopathies .
- Aspirin is usual.
- Anticoagulation is considered for cardioembolism and selected dissections (see caveats).
- Sickle cell disease (STOP trial, 130 children) :
- Who: children with TCD velocity ≥200 cm/s in the ICA or MCA.
- Intervention: chronic transfusion to HbS below 30%.
- Result: 92% fewer first strokes (1 vs. 11 events); the trial stopped early.
- Acute stroke in sickle cell is treated with exchange transfusion (see caveats).
- Moyamoya: surgical revascularization; see Moyamoya.
Related topics
- Moyamoya Disease and Syndrome: revascularization for the arteriopathy with the highest recurrence.
- Cerebral Sinovenous Thrombosis: the venous counterpart of pediatric stroke.
- Hereditary Vasculopathies: inherited arteriopathies and dissection.
- Cerebral Proliferative Angiopathy: ischemic presentation of an angiopathy.
- Hemispherectomy in Children: post-stroke hemispheric epilepsy.
- Central Nervous System Tuberculosis: Neurosurgical Implications: vasculitic stroke in tuberculous meningitis.
- Decompressive Hemicraniectomy: step-by-step procedure.
- EC–IC Bypass (Direct STA–MCA Revascularization): step-by-step procedure.
- Pial Synangiosis: step-by-step procedure.
References
- Ferriero DM, Fullerton HJ, Bernard TJ, et al. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2019;50(3):e51–e96. doi:10.1161/STR.0000000000000183. PMID 30686119. verified
- Mallick AA, Ganesan V, Kirkham FJ, et al. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol 2014;13(1):35–43. doi:10.1016/S1474-4422(13)70290-470290-4). PMID 24304598. verified
- Fullerton HJ, Wintermark M, Hills NK, et al. Risk of recurrent arterial ischemic stroke in childhood: a prospective international study. Stroke 2016;47(1):53–59. doi:10.1161/STROKEAHA.115.011173. PMID 26556824. verified
- Fullerton HJ, Stence N, Hills NK, et al. Focal cerebral arteriopathy of childhood: novel severity score and natural history. Stroke 2018;49(11):2590–2596. doi:10.1161/STROKEAHA.118.021556. PMID 30355212. verified
- Amlie-Lefond C, Shaw DWW, Cooper A, et al. Risk of intracranial hemorrhage following intravenous tPA (tissue-type plasminogen activator) for acute stroke is low in children. Stroke 2020;51(2):542–548. doi:10.1161/STROKEAHA.119.027225. PMID 31842706. verified
- Sporns PB, Bhatia K, Abruzzo T, et al. Endovascular thrombectomy for childhood stroke (Save ChildS Pro): an international, multicentre, prospective registry study. Lancet Child Adolesc Health 2024;8(12):882–890. doi:10.1016/S2352-4642(24)00233-500233-5). PMID 39401507. verified
- Bhatia K, Kortman H, Blair C, et al. Mechanical thrombectomy in pediatric stroke: systematic review, individual patient data meta-analysis, and case series. J Neurosurg Pediatr 2019;24(5):558–571. doi:10.3171/2019.5.PEDS19126. PMID 31398697. verified
- Bhatia KD, Muthusami P, Parra-Farinas C, et al. Thrombectomy versus medical management for pediatric arterial ischemic stroke with large baseline infarct. Stroke 2025;56(9):2440–2449. doi:10.1161/STROKEAHA.125.050993. PMID 40557480. verified
- Lehman LL, deVeber G, Pergami P, et al. Characteristics and outcome in children with craniectomy following acute ischemic stroke in the International Pediatric Stroke Study. J Child Neurol 2019;34(12):765–769. doi:10.1177/0883073819855534. PMID 31282248. verified
- Carlhan-Ledermann A, Bartoli A, Gebistorf F, et al. Decompressive hemicraniectomy in pediatric malignant arterial ischemic stroke: a case-based review. Childs Nerv Syst 2023;39(9):2377–2389. doi:10.1007/s00381-023-06086-w. PMID 37493722. verified
- Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339(1):5–11. doi:10.1056/NEJM199807023390102. PMID 9647873. verified
Verification (2026-11-17):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
- The full text of the AHA statement (1) could not be retrieved, so only its abstract figures are cited.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- the practical workflow;
- stroke mimics;
- the aspirin/anticoagulation choices;
- exchange transfusion for acute sickle cell stroke;
- posterior fossa decompression indications.
- Alteplase and thrombectomy data come from registries and retrospective series, not pediatric RCTs.
- The figure is an original schematic.